All Stories
IRES: Home sale prices, listings continue to climb
Median home sale prices in Northern Colorado and the Boulder Valley continued to grow in August, as did listings, according to data compiled by Information and Real Estate Services LLC,...
Leeds Business Confidence Index has pessimistic outlook for fourth quarter
Business leaders in Colorado expressed pessimism about the state’s economic outlook ahead of the fourth quarter of 2022.
Leeds Business Confidence Index has pessimistic outlook for fourth quarter
Business leaders in Colorado expressed pessimism about the state’s economic outlook ahead of the fourth quarter of 2022.
Atom Computing opens new Boulder facility
Atom Computing Inc. on Wednesday opened a new research and development facility in Boulder that the quantum computing company will use to house future generations of its computers.
Edgewise Therapeutics receives FDA approval for drug trials, begins stock offering
Edgewise Therapeutics Inc. has received authorization from the U.S. Food and Drug Administration to conduct Phase 2 clinical trials for EDG-5506, its flagship muscular dystrophy drug candidate, the company announced...
Brickell Biotech again faces delisting from Nasdaq
Brickell Biotech Inc. received a notice last week that it faces delisting from the stock exchange after the July resignation of Dennison T. Veru from its board of directors.
NCAR Aviation facility reopens
The National Center for Atmospheric Research and University Corporation for Atmospheric Research on Wednesday celebrated the official completion of its redeveloped Research Aviation Facility at the Rocky Mountain Regional Airport.
Sanitas Brewing to open new taproom in Englewood
Sanitas Brewing Co. is planning to open a second location with a taproom in Englewood. It will be located at 200 W. Belleview Ave.
Encision revenue grows 7%
Medical device manufacturer Encision Inc. experienced 7% revenue growth in the first quarter of its 2023 fiscal year, the company reported Tuesday.
Arca Biopharma slows losses, R and D expenses in Q2
Arca Biopharma Inc. saw its losses for the second quarter of 2022 shrink by 33%, to $3.2 million from a $4.8 million net loss in the second quarter of 2021....